Ronald C W Ma Selected Research

2,4-thiazolidinedione (thiazolidinedione)

5/2014	Additive effects of blood glucose lowering drugs, statins and renin-angiotensin system blockers on all-site cancer risk in patients with type 2 diabetes.
7/2012	Use of thiazolidinedione and cancer risk in Type 2 diabetes: the Hong Kong diabetes registry.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ronald C W Ma Research Topics

Disease

65	Type 2 Diabetes Mellitus (MODY) 02/2024 - 11/2002
19	Neoplasms (Cancer) 01/2023 - 03/2008
13	Albuminuria 02/2024 - 11/2002
13	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 11/2010
12	Obesity 02/2024 - 12/2005
11	Insulin Resistance 03/2024 - 11/2002
9	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2024 - 09/2007
9	Chronic Renal Insufficiency 12/2023 - 04/2014
9	Hypoglycemia (Reactive Hypoglycemia) 01/2023 - 04/2014
7	Diabetic Nephropathies (Diabetic Nephropathy) 02/2024 - 11/2003
7	Hyperglycemia 02/2016 - 05/2007
6	Coronary Disease (Coronary Heart Disease) 01/2024 - 01/2020
6	Heart Failure 11/2023 - 09/2004
5	Genetic Risk Score 01/2024 - 01/2020
5	Chronic Kidney Failure (Chronic Renal Failure) 01/2023 - 08/2010
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 12/2005
5	Inflammation (Inflammations) 12/2021 - 10/2016
4	Glucose Intolerance 12/2023 - 09/2007
3	Overweight 02/2024 - 05/2011
3	Prediabetic State (Prediabetes) 12/2023 - 08/2018
3	Ischemic Stroke 11/2023 - 12/2008
3	Metabolic Diseases (Metabolic Disease) 12/2022 - 01/2015
3	Weight Loss (Weight Reduction) 01/2022 - 11/2002
3	Body Weight (Weight, Body) 01/2021 - 11/2002
3	Dyslipidemias (Dyslipidemia) 01/2021 - 05/2007
3	Stroke (Strokes) 12/2020 - 09/2004
3	Fibrosis (Cirrhosis) 01/2020 - 04/2005
3	Diabetes Complications 01/2019 - 08/2010
2	Mason-Type Diabetes 02/2023 - 11/2003
2	Acute Kidney Injury (Acute Renal Failure) 01/2023 - 01/2007
2	Lactic Acidosis 09/2022 - 01/2021
2	Cushing Syndrome 08/2014 - 02/2005
2	Diabetes Mellitus 09/2007 - 12/2005
2	Myocardial Ischemia (Ischemic Heart Diseases) 04/2005 - 09/2004
1	Hypertension (High Blood Pressure) 04/2024
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 02/2024
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 02/2024
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 02/2024

Drug/Important Bio-Agent (IBA)

31	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 11/2002
27	Insulin (Novolin)FDA Link 03/2024 - 05/2007
14	Triglycerides (Triacylglycerol)IBA 01/2024 - 11/2002
12	LDL CholesterolIBA 12/2023 - 08/2008
11	Biomarkers (Surrogate Marker)IBA 02/2024 - 01/2017
11	LipidsIBA 01/2023 - 11/2002
10	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2023 - 08/2008
8	Metformin (Glucophage)FDA LinkGeneric 09/2022 - 12/2010
8	CreatinineIBA 01/2022 - 09/2004
6	oxidized low density lipoproteinIBA 12/2023 - 12/2012
6	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 06/2022 - 11/2002
5	C-Reactive ProteinIBA 01/2024 - 12/2005
4	AlbuminsIBA 02/2024 - 03/2008
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2020
4	HDL CholesterolIBA 12/2012 - 06/2008
4	Insulin-Like Growth Factor I (IGF-1)IBA 05/2011 - 12/2005
3	C-PeptideIBA 03/2024 - 01/2022
3	Fatty Acids (Saturated Fatty Acids)IBA 02/2024 - 11/2021
3	CalciumIBA 01/2024 - 01/2007
3	PotassiumIBA 01/2023 - 01/2014
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 10/2016
3	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2020 - 01/2018
3	Testosterone (Sustanon)FDA Link 01/2019 - 12/2005
3	CholesterolIBA 07/2012 - 06/2008
2	Blood Glucose (Blood Sugar)IBA 04/2024 - 05/2014
2	HDL LipoproteinsIBA 02/2024 - 12/2022
2	ElectrolytesIBA 02/2024 - 01/2007
2	Troponin T (Troponin T1)IBA 01/2024 - 08/2023
2	Galectin 3 (LGALS3)IBA 01/2024 - 08/2023
2	pro-brain natriuretic peptide (1-76)IBA 01/2024 - 08/2023
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2024 - 08/2023
2	Troponin IIBA 01/2024 - 08/2023
2	Trinitrotoluene (TNT)IBA 01/2024 - 08/2023
2	GlucokinaseIBA 02/2023 - 01/2022
2	SodiumIBA 01/2023 - 01/2016
2	AntibodiesIBA 01/2023 - 01/2019
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2023 - 09/2004
2	Phospholipids (Phosphatides)FDA LinkGeneric 12/2022 - 11/2021
2	Hemoglobins (Hemoglobin)IBA 01/2022 - 03/2008
2	Bile Acids and Salts (Bile Acids)IBA 01/2020 - 09/2018
2	Long Noncoding RNAIBA 01/2019 - 01/2018
2	Hydrocortisone (Cortisol)FDA LinkGeneric 06/2014 - 12/2010
2	2,4-thiazolidinedione (thiazolidinedione)IBA 05/2014 - 07/2012
2	Fibric Acids (Fibrates)IBA 05/2014 - 12/2012
2	Aldehyde Reductase (Aldose Reductase)IBA 03/2014 - 11/2008
2	Insulin-Like Growth Factor Binding Protein 3IBA 05/2011 - 09/2010
1	Phenylalanine (L-Phenylalanine)FDA Link 02/2024
1	ApolipoproteinsIBA 02/2024
1	Glycoproteins (Glycoprotein)IBA 02/2024
1	Tyrosine (L-Tyrosine)FDA Link 02/2024
1	semaglutideIBA 02/2024
1	FluorocarbonsIBA 01/2024
1	OligosaccharidesIBA 12/2023
1	CarbohydratesIBA 12/2023
1	Polysaccharides (Glycans)IBA 12/2023
1	MonosaccharidesIBA 12/2023

Therapy/Procedure

9	Glycemic Control 12/2022 - 11/2002
8	Therapeutics 11/2021 - 11/2002
3	Precision Medicine 01/2024 - 08/2023
3	Surgical Amputation (Amputations) 11/2023 - 12/2020
2	Renal Replacement Therapy (Therapies, Renal Replacement) 11/2023 - 06/2021
1	Subcutaneous Injections 02/2024